Objective. Curcuma longa (C. longa) was used in some countries such as China and India for various medicinal purposes. Curcumin, the active component of C. longa, is commonly used as a coloring agent in foods, drugs, and cosmetics. C. longa and curcumin have been known to act as antioxidant, anti-infl ammatory, anti-mutagen, and anti-carcinogenic agents. Th e attempt of the present review was to give an eff ort on a detailed literature survey concentrated on the protective eff ects of C. longa and curcumin on the reproductive organs activity.
Medical plants have been considered as a major source of therapeutic agents in the traditional medicine to cure human diseases. Th e use of the medicinal plants and traditional medicine was interested and started mainly in the last decade because it was a belief that the natural drugs are healthier than the synthetic ones (Cragg and Newman 2005) . Turmeric is a spice derived from the Curcuma longa (C. longa) rhizomes (Eigner and Scholz 1999) . Th e yellow color of turmeric comes from the polyphenolic pigments known as curcuminoids (Araujo and Leon 2001) . Turmeric has been used in India for diff erent medicinal purposes since centuries (Akram et al. 2010) . It has been reported that C. longa extract has renal protective (Aggarwal and Harikumar 2009; Mohebbati et al. 2016) , hepatoprotective (Deshpande et al. 1998; Naik et al. 2004; Khazdair et al. 2016) , cardioprotective (Mohanty et al. 2004; Aggarwal and Harikumar 2009; Srivastava and Mehta 2009) , anti-diabetic (Kowluru and Kanwar 2007) , neuroprotective (Shukla et al. 2003; Aggarwal and Harikumar 2009) , and gonadoprotective eff ects (Ilbey et al. 2009; Azza et al. 2011 ).
Curcumin is the major and active biological compound of C. longa. Th e major therapeutic eff ects of C. longa was attributed to the curcumin (Sharma et al. 2005) . Th e pharmacological safety of curcumin has been revealed (Ammon and Wahl 1991) and its safety for human consumption has been approved by the U.S. Food and Drug Administration (FDA) (Chainani-Wu 2003) .
Th e pharmacological eff ects of curcumin, including anti-infl ammatory (Jurenka 2009 ), antioxidant, and anticancer ones (Kuttan et al. 1985; Swany et al. 2008; Aggarwal and Harikumar 2009; Wilken et al. 2011) , have been reported. Th e anti-carcinogenic effects of curcumin due to free-radical scavenging, as well as their ability to increase glutathione levels, and relieving in hepatic detoxifi cation of mutagens and carcinogens, have been shown (Kunchandy and Rao 1990; Akram et al. 2010) .
Th e results of the studies have shown that curcumin exerts advantageous eff ects on the sexual glands, testis, and ovary, which may be due to antioxidant (Sahoo et al. 2008) , anti-infl ammatory (Farombi et al. 2007 ), anti-cancer (Cort et al. 2012) , and anti-apoptotic properties (Aktas et al. 2012) . Th erefore, in this article we reviewed the eff ects of C. longa and curcumin on sexual glands, testis and ovary, in the in vitro and in vivo conditions. Th e data of this review article have been obtained by searching in PubMed, Web of Science, Google Scholar, Scopus, and IranMedex until the end of March 2017. Th e search terms were "testis" or "ovary" and "Curcuma longa", "curcumin", "antioxidant eff ect", "anti-infl ammatory eff ect" and "anti-cancer eff ect".
Th e eff ect of C. Longa and curcumin on male reproductive system
In vitro (cellular) studies. Th e anti-inflammatory activity of C. longa extracts on LPS-induced production of tumor necrosis factor alpha (TNF-α) and prostaglandin E2 (PGE 2 ) in HL-60 cells showed that C. longa inhibited production of TNF-α and PGE 2 in HL-60 cells (Lantz et al. 2005) .
Th e pro-apoptotic eff ect of the curcumin on the human neutrophil apoptosis has been evaluated. Curcumin (10-50 μM) increased the constitutive neutrophil apoptosis and decreased the migration and myeloperoxidase releases. Curcumin applied proapoptotic eff ect on the human neutrophil is acting via p38 mitogen-activated protein kinase (MAPK) or increasing in caspase-3 activity (Hu et al. 2005) .
Th e apoptotic potential of the curcumin on both the androgen-dependent and the androgen-independent prostate cancer cells showed that 2% curcumin in the synthetic diet signifi cantly decreased the extent of cell proliferation and signifi cantly increased the extent of the apoptosis, which was measured by in situ cell death assay. Furthermore, curcumin signifi cantly decreased the micro vessel density in the androgen-dependent LNCaP prostate cancer cells (Dorai et al. 2001) . Th e eff ects of the curcumin and bleomycin on apoptosis in human malignant testicular germ cells (NCCIT cells) have been investigated. Curcumin (5 μM), H 2 O 2 (35 μM) and bleomycin (120 μg/ml) increased the apoptotic markers, including caspases (3, 8 and 9) activities, Bax and cytoplasmic Cyt-C levels but decreased the Bcl-2 level (Cort et al. 2013) .
It has been reported that curcumin (5, 10 and 15 μM) inhibited the viability of NTera-2 human malignant testicular germ cells (Zhou et al. 2013) . Curcumin has been revealed to inhibit the colony formation in both NTera-2 and F9 mouse teratocarcinoma stem cells. It has been proposed that curcumin (15 μM) can suppress AP-2γ, a marker of testicular germ cell tumors, and inhibit amplifi cation and expression of NTera-2 cells (Zhou et al. 2013 ).
In vivo (animal) studies. Administration of C. longa extract (1 mg/kg, p.o.) reduced the serum levels of cholesterol, triglycerides, and phospholipids as well as the fertility in the male rats (Purohit 1999) . Aqueous rhizome extract of C. longa (600 mg/kg b.w. per day for 56 and 84 days) orally administered to male mice of the Parkes (P) strain signifi cantly reduced the weights of the testis, epididymis, and seminal vesicle compared to controls. Moreover, the number of spermatozoa in cauda epididymidis, motility, and viability were signifi cantly reduced, whereas the number of morphologically abnormal spermatozoa in the extract-treated group signifi cantly increased compared to the control group (Mishra and Singh 2009) . C. longa extract also reduced the diameter of the seminiferous tubules, the height of the germinal epithelium, the levels of sialic acid in the epididymis, fructose in the seminal vesicle, and serum level of testosterone, while ;the muscle layer surrounding the glandular epithelium increased compared to the control group (Mishra and Singh 2009) .
Th e aqueous and alcoholic extracts of C. longa (500 mg/kg for 60 days) decreased the seminal vesicle and ventral prostate, and the weight of testes and epididymides in male albino rats. It has been shown that the aqueous and alcoholic extract of C. longa decreased the sperm motility in cauda epididymides, and sperm density in the testes and cauda epididymi-des. Both of the extracts also reduced the size of the seminiferous tubules of testes, number of spermatogonia, spermatocytes, and spermatids. Th e seminiferous tubules and Leydig cells nuclei diameters were signifi cantly reduced in the extract-treated groups compared to control. (Ashok and Meenakshi 2004) .
Th e acute and chronic oral toxicity of ethanolic extracts of C. longa in mice were studied. Th e sperm motility and sperm counts increased in both acute dosages (0.5, 1 and 3 g/kg) and the chronic dose of extract (100 mg/kg) (Qureshi et al. 1992) .
Eff ects of C. longa and curcumin on adverse reproductive eff ects induced by water nitrate pollution in male rats have been examined (Azza et al. 2011) . Th e results have shown that in nitrate-exposed rats, the serum levels of testosterone, dehydroepiandrosterone (DHEA), epididymal sperm number, total protein, RNA, and DNA contents in serum and testis signifi cantly decreased, whereas lipid profi le, including total lipid, total cholesterol, triglycerides, and phospholipids were signifi cantly increased in serum and testis. Testicular antioxidant components, including superoxide dismutase (SOD), glutathione (GSH), and γ-glutamyl transpeptidase (γ-GT), were reduced in testis of nitrate-exposed rats. C. longa (1% w/w) and curcumin (20 mg/kg, p.o.) have been shown to be effective in reducing the nitrate-induced reproductive alterations, as shown by normalized lipid peroxidation, lipid profi le, antioxidant components, total protein, DNA, RNA, and sperm number (Azza et al. 2011) .
Th ese results have indicated that the aqueous extract of C. longa had adverse eff ects on the spermatogenesis, motility, morphology, viability, and number of spermatozoa in the cauda epididymidis, and these adverse eff ects were caused due to the eff ects on function of the gland and defi ciency of testosterone. Furthermore, acute and the chronic doses of C. longa extract increased sperm motility and sperm counts, which may be due to eff ects of the C. longa extract on function of the gland.
Th e role of the curcumin on pesticide lindane-induced adverse eff ects on the testis has been studied (Sharma and Singh 2010) . Administration of curcumin (100 mg/kg) to lindane-exposed male Wistar rats (daily 30 mg/kg) resulted in decreasing testicular sperm head count, weight of testes and cauda epididymis, and sperm motility, while increased abnormal tail and head sperm morphology. In addition, the curcumin improved lindane-induced reproductive toxicity including decline in superoxide dismutase, catalase, and glutathione-s-transferase activity (Sharma and Singh 2010) .
Th e eff ect of the curcumin against acute cadmium chloride (CdCl 2 ) toxicity on the reproductive system in male rats has been investigated (Oguzturk et al. 2012) . CdCl 2 led to a signifi cant increase in oxidative stress. Curcumin (1 mg/kg) induced antioxidant effects and improved CdCl 2 -caused oxidative damage. Th e epididymal sperm concentration and sperm motility signifi cantly decreased in CdCl 2 -exposed group and the sperm characteristics were recovered aft er treating with curcumin. In addition, CdCl 2 administration resulted in vacuities, edema, hemorrhage, and acute infl ammatory cells infi ltration in the interstitial space. Administration of curcumin aft er CdCl 2 toxicity reduced the severity of histopathological changes (Oguzturk et al. 2012) .
Th e eff ects of the curcumin on inducible nitric oxide synthase (iNOS) expression, nuclear factor-kappa B (NF-kB) activation, and MAPK in the pathogenesis of testicular damage induced by cisplatin (CIS) have been investigated (Ilbey et al. 2009 ). Curcumin (200 mg/kg, p.o.) increased plasma testosterone levels, GSH levels, and glutathione peroxidase (GSH-Px) activity and decreased MDA and NO levels in the testicular tissue compared with the CIS-induced toxicity group (Ilbey et al. 2009) .
Th e protective eff ects of the curcumin on chronic alcohol-exposed Leydig cells have been studied in male mice (Giannessi et al. 2008) . Th e results have indicated that the rarefaction of cytoplasmic cells, increasing the diameter of mitochondria, reducing testosterone plasma level as well as necrosis of Leydig cells take place in the alcohol-fed mice. Administration of the curcumin (80 mg/kg) led to a reduction of the number of necrotic Leydig cells and the diameter of the mitochondria in alcohol plus curcumin-treated mice compared with alcohol-fed mice (Giannessi et al. 2008) . Th ese results have indicated that C. longa extracts and curcumin exhibit therapeutic eff ects on the male reproductive system via antioxidant and anti-infl ammatory eff ects.
Th e eff ect of C. longa and curcumin on the female reproductive system
In vitro (cellular) studies. Curcumin has been revealed to have antiviral, antibacterial anti-proliferation, and anti-angiogenic eff ects (Aggarwal et al. 2003) . Curcumin has been also suggested to suppress the factors linked with tumorigenesis agents such as vascular endothelial growth factor (VEGF), phosphorylated signal transducers and activators of transcription 3 (STAT), and matrix metalloproteinase-9 (MMP-9) (Holt et al. 2005) . Curcumin has been reported to have effi cacy in ovarian carcinoma models through the anti-tumorigenic and anti-angiogenic mechanisms, and these eff ects are suggested to be mediated via the NF-κB, STAT3, interleukin-6 (IL-6), MMP-9 and VEGF (Lin et al. 2007) .
It has been documented that C. longa extract (0.4 mg/ml) may inhibit the cell growth in Chinese Hamster Ovary (CHO) cells. Furthermore, it has been reported that curcumin, in sub-lethal dose, increased Apo2L/TRAIL-caused cell death in CIS-resistant ovarian cancer cell lines (Wahl et al. 2007) .
Th e curcumin has been suggested to suppress the proliferation and induce apoptosis in the human ovarian cancer cell line Ho-8910 (Shi et al. 2006) . One of the most important tumor suppressors is p53, which can induce apoptosis by activating downstream genes in a sequence-specifi c manner (Harris and Levine 2005; Yu and Zhang 2005) . It has been shown that treatment of the human ovarian cancer cell line Ho-8910 with curcumin for 24 h increased the total p53 level. Th is subject implies to a possible role of p53 in apoptosis caused by curcumin in Ho-8910 cells. In addition, it has been reported that treatment with curcumin decreased the level of antiapoptotic, such as Bcl-2 and Bcl-X L , and increase the level of pro-apoptotic factor Bax in Ho-8910 cells (Shi et al. 2006) .
Th e curcumin has also been suggested to arrest the cell-cycle in many diff erent tumor cells through up-regulating Cdk-1, cdc2, NFκB (Park et al. 2002; Aggarwal et al. 2006) . It has been reported that curcumin synergistically enhances the eff ect of platinum drugs such as cisplatin and oxaliplatin on the cell cycle arrest and ameliorates eff ect these drugs on ovarian cancer patients (Montopoli et al. 2009 ). AMP-activated protein kinase (AMPK) regulates the involved cellular processes in cellular energy status (Hardie and Carling 1997) . Recently, scientifi c evidences have shown that AMPK activation may inhibit the cell proliferation and induce cell apoptosis in cancer cells (Nagata et al. 2004) . It has been suggested that curcumin-induced cell death in CaOV3 ovarian cancer cells through activating p38-dependent AMPK is reversible by AMPK and p38 inhibitors (Pan et al. 2008) .
Th e protective eff ect of p53, a tumor suppressor protein, against cancer has been well documented. p53 has been exhibited to involve in the cytotoxic action of chemotherapeutic drugs on cancer cells (Zunino et al. 1997; Siddik 2003) . Th e curcumin has been shown to have cytotoxic eff ect on MCS consisting of three-dimensional aggregation of wild-type p53 OVCA429 or null p53 SKOV3 ovarian cancer cells (Watson et al. 2010 ).
In the curcumin-treated HEY ovarian carcinoma cells, the hallmarks of apoptosis such as nuclear condensation and nuclear and DNA fragmentation also happen (Martelli et al. 2001) . Th e cleavage of PARP-1 by caspase-3 plays a crucial role in the initiation of the apoptosis (Cohen 1997). It has been reported that treatment with curcumin induces caspase-3 activation and the subsequent cleavage of PARP-1 in Hey cells and HO-8910 ovarian cancer cells (Shi et al. 2006 ). In addition, the scientifi c evidences have shown that curcumin-caused apoptosis in HEY ovarian carcinoma cells was associated with reduced expression of anti-apoptotic proteins including suvivin and Bcl-2 (Watson et al. 2010) .
Recently, the curcumin has been shown to induce ceramide generation to stimulate cancer cell apoptosis (Moussavi et al. 2006) . It seems that increasing agents of the intracellular ceramide levels could enhance tumor cell cytotoxicity and apoptosis caused by curcumin (Yu et al. 2012 ). Sphingosine kinase-1 (SphK1) has been proposed as a potent oncogene for ovarian cancer which is expressed in clinical ovarian tissues and in cultured ovarian cancer cells. It has been reported that SphK1 inhibition by siRNA knockdown and pharmacological inhibitor SKI-II can facilitate curcumin-caused cytotoxicity and apoptosis (Yang et al. 2012) .
Th e aquaporins (AQPs), integral membrane proteins, have been shown to be expressed in multiple epithelial and endothelial transporting fl uids (Verkman 2005) as well as tumor cells (Moon et al. 2003; Hu and Verkman 2006) . In in vitro and in vivo, AQPs can also facilitate tumor cell migration across the blood vessels (Hu and Verkman 2006) . Th e curcumin has been documented to reduce epidermal growth factor (EGF)-caused AQP3 upregulation and cell migration in ovarian cancer cells (Ji et al. 2008) .
In some studies, NF-κB has been considered as an important player in tumor growth (Dobrovolskaia and Kozlov 2005; Van Laere et al. 2006) , cell proliferation, apoptosis (Yamamoto and Gaynor 2001) , and tumor chemo-resistance . Regarding to these eff ects, NF-κB might be an important clinical therapeutic target. Th e results of many studies have indicated that curcumin inhibits NF-κB activation, tumor growth, and angiogenesis in the ovarian carcinoma models when it was orally administered (Lin et al. 2007) .
Th e curcumin have shown anti-apoptotic eff ects via inhibition of the angiogenesis such as inhibition of the fi broblast growth factor (FGF), VEGF, and angiopoietin 1 and 2 regulated cell adhesion molecules, such as endothelial leukocyte adhesion molecule-1 (ELAM-1), intracellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) (Gururaj et al. 2002) and enhancement of the cancer inhibitor protein (p53) in normal cell lines and also activation of the pro-apoptotic agent, including angiogenesis and caspase 9, 8, and 3, in malignant cell lines (Cort et al. 2013) . It has also been reported that the curcumin can reduce the ovarian ischemia/reperfusion injury via decreasing the oxidative stress markers (Sak et al. 2013) .
In another study, chlorpyrifos (CPF) (10 and 20 mg/kg) has been administered to mice by Gavage method, then histological alteration of the ovary and uterus was examined under the light microscope. In addition, oxidative stress levels were studied by determining the lipid peroxidation levels, and hormonal changes (FSH) to evaluate the fertility rate. CPF-treated group has shown ruptured germinal epithelium with multiple nuclei and matured Graafi an follicles with degenerated ovum. Corpus luteum cells were observed to be rudimentary. Unusual number of vacuolated spaces was observed in ovarian cortex. Th us, the study has revealed that CPF causes degeneration of Graafi an follicle and germinal epithelium of ovary leading to infertility in female mice. Control uterus showed well-defi ned longitudinal and circular muscles on periphery with well-structured endometrial cells and glands. In CPF-treated group, the degeneration of circular and longitudinal muscles was observed on the periphery with clustered endothelial cells at lower concentration. At higher concentrations, degeneration in circular muscles was prominent. Longitudinal muscles were also on periphery with many vacuolated spaces along with vacuolated endometrial cells and glands which were also rudimentary in structure. Th e remediation effect with curcumin has been shown with better and more satisfactory results in histopathology as well as biochemical aspects (Raj et al. 2011) . Th is study has shown that inhibition of implantation reduction of estrogen level and increment of progesterone level may be as the possible mechanism of antifertility effect of the ethanolic extract of C. longa.
Conclusions
In the recent years, the traditional medicine using natural products have received much more attention, because they were considered to be more safety for human than the synthetic drugs. C. longa and curcumin have been reported to possess anti-infl ammatory, antioxidant, and anti-cancer eff ects. C. longa and curcumin protect gonad cells against ROS and carcinogenic agents. In addition, C. longa and curcumin may increase the anti-apoptotic factors such as Bcl-2 and Bcl-X L and decrease the apoptotic agents such as Bax in normal cell lines. Moreover, diff erent eff ects of C. longa and curcumin are dependent on the doses and the type of cells used in various models studied. Th e therapeutic eff ect of the curcumin on the reproductive malignancy was more eff ective than C. longa extract in in vitro and in vivo studies. Generally, the curcumin showed anti-infl ammatory and anti-apoptotic eff ects via inhibition of the angiogenesis, regulation of the cell adhesion molecules and enhancement of the cancer inhibitory protein (p53) in normal cell lines and also activation of pro-apoptotic agent induced angiogenesis and caspase 9, 8, and 3 in malignant cell lines.
